ClinicalTrials.Veeva

Menu

Caudal Block With Bupivacaine and Dexmedetomidine Versus TAP Block With Bupivacaine Alone for Postoperative Analgesia in Pediatric Undergoing Infraumbical Surgeries

S

Sohag University

Status and phase

Enrolling
Phase 2

Conditions

Postoperative Pain

Treatments

Procedure: TAP
Drug: Dexmedetomidine
Drug: Bupivacain
Procedure: caudal block

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Acute pain management for pediatric surgical patients intraoperatively and postoperatively is important for their comfort and psychological impact. Children aged 3-9 years old are included in the study and are divided randomly into two groups (45 children in each):

Group D: Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg.

Group T: TAP block with bupivacaine 0.25% in a dose of (0.5 ml / kg).

Enrollment

90 estimated patients

Sex

All

Ages

3 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children aged 3-9 years old
  • Physical status I and II class of the American Society of Anesthesiologists (ASA)
  • Unilateral elective surgeries below the umbilicus

Exclusion criteria

  • Parents or legal guardian refusal.
  • History of developmental delay or mental retardation
  • Contraindications to regional anesthesia as known or suspected coagulopathy, a known allergy to any of the study drugs, signs of infection at the site of caudal block.
  • Hemodynamic unstable patient.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

90 participants in 2 patient groups

Caudal block with bupivacaine and dexmedetomidine
Active Comparator group
Description:
Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg.
Treatment:
Procedure: caudal block
Drug: Bupivacain
Drug: Dexmedetomidine
TAP block with bupivacaine
Active Comparator group
Description:
TAP block with bupivacaine 0.25% in a dose of (0.5 ml / kg).
Treatment:
Drug: Bupivacain
Procedure: TAP

Trial contacts and locations

1

Loading...

Central trial contact

Fouad I Soliman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems